Back to results
US 12,357,700 B2Granted
Combination therapy method of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate in combination with other agents
AssigneeStemline Therapeutics, Inc.
InventorIvan Bergstein
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for treating or inhibiting a myeloproliferative neoplasm (MPN) in a subject in need thereof, comprising administering to the subject a diphtheria toxin-human interleukin-3 conjugate (DT-IL3) and one or more Jak inhibitors and/or one or more hypomethylating agents.
Claims19
A method for treating or inhibiting a myeloproliferative neoplasm (MPN) in a human subject in need thereof, comprising administering to the subject a diphtheria toxin-human interleukin-3 conjugate (DT-IL3) and
- a. one or more Jak inhibitors and/or
- b. one or more hypomethylating agents.
Dependencies are inferred from the claim text.